
Skin Longevity Is Rewriting Skin Care R&D. Is Your Team Built for It?
For years, anti-aging skin care meant a hero ingredient and a strong marketing story. That model is changing. The largest players are now building their science around how skin cells age, repair and renew, and that shift changes who they need to hire.
This month, The Estée Lauder Companies put a stake in the ground with a company-wide platform it calls Mastering Skin Longevity. Smaller brands are heading the same way through biotech artnerships. If you lead an R&D, product development or marketing team in skin care, this is a talent story as much as a science story.
What Estée Lauder announced
On November 6, Estée Lauder Companies unveiled Mastering Skin Longevity at the China International Import Expo in Shanghai. It is not a single launch. It is meant to be a shared scientific foundation that the company’s skin care brands build on.
The approach moves away from treating individual signs of aging one at a time. Instead, ELC is focusing on what it calls Master Regulators. These are three cellular pathways: sirtuins for repair and stress response, AMPK for cellular energy, and mTOR for renewal.
Each brand has a role. Estée Lauder leads on sirtuins and epigenetics, La Mer on cellular energy, and Clinique on clinically proven skin resilience. Lab Series covers men, and The Ordinary brings its evidence-based ingredient approach.
The company is putting real infrastructure behind it. There are dedicated Longevity Labs in Melville, New York, and in Shanghai, plus a new scientific advisory board with experts from China, Singapore and the United States. René Lammers, ELC’s chief research and innovation officer, called it “a more integrated foundation for discovery.” ELC says the platform draws on two decades of longevity research. It also released a white paper and new skin analysis tools alongside it.
It is not only the giants
Professional and mid-size brands are reaching the same goal through biotech. Dermalogica has partnered with Core Biogenesis, a French biotech that uses plants as small factories to produce growth factors. In a recent Cosmetics & Toiletries Q&A, the two companies described turning a growth factor made from Camelina seeds into a finished eye serum.
Their list of hurdles reads like a set of job descriptions. They had to keep a fragile biological ingredient stable, get it into the skin, keep it gentle, prove results clinically and scale up production. Dermalogica reports a 129% increase in under-eye density at four weeks in its testing.
Money is following the science as well. Cosmetics & Toiletries reported this week that Bloomage Biotech, the Chinese ingredient maker, has backed Alaris, a young Los Angeles skin care brand. Trade coverage also shows longevity language spreading beyond skin care into eye shadow and lip care.
What it means for hiring
My view is simple. Skin longevity will separate teams that can do the science from teams that can only talk about it. The talent to do it well is thin, and the companies moving first are already building their benches.
These are the roles I expect to tighten first:
Cell biology and biotech scientists who understand pathways like sirtuins and growth factors and can turn lab findings into cosmetic actives.
- Formulation chemists with biological actives experience, because keeping fragile ingredients stable and delivering them is different from classic emulsion work.
- Clinical and claims specialists who can design studies and word longevity claims so they hold up.
- Regulatory and safety professionals who can document new biotech ingredients for several markets at once.
- Science-fluent marketers and educators who can explain epigenetics to a consumer or an esthetician without overpromising.
Sourcing and supply chain teams will feel it too. Biotech actives often come from newer, smaller suppliers, and someone has to qualify them.
In searches like this, we often find strong candidates just outside beauty, in pharma, biotech, dermatology or food science. They bring the science but need time to learn cosmetic regulations, timelines and margins. Employers who plan for that learning curve, and sell candidates on the category, tend to win those hires.
So map your bench now, before a competitor’s launch forces the issue. Decide which skills to build, which to hire and which to borrow through ingredient partners. And start conversation searly, because the best scientists are rarely looking for a job.
Also on our radar
- Justin Boxford, who led Estée Lauder’s luxury brands, will become CEO of Capri Holdings on January 4, succeeding John Idol.
- Coty plans to cut about 155 of its roughly 200 jobs in France, including marketing, sales and supply chain roles in Paris, according to unions cited by Reuters.
- Ulta Beauty is bringing the Oura Ring 5 into about 1,000 stores this month, its first step into health wearables.
in health and beauty since 2005. If skin longevity is on your roadmap, I would welcome a conversation about the team it will take.
Michael Rowe, Managing Partner, Momentum Search Consultants
Sources
- Premium Beauty News, citing Reuters and AFP, Coty job cuts in France, November 2026
- The Estée Lauder Companies, press release on Mastering Skin Longevity, November 6, 2026
- Cosmetics Business, coverage of ELC’s Mastering Skin Longevity platform, November 9, 2026
- Personal Care Insights, coverage of ELC’s skin longevity platform, November 9, 2026
- Cosmetics & Toiletries, Q&A with Dermalogica and Core Biogenesis on biotech skin care, October 28, 2026
- Cosmetics Business, inside Dermalogica’s innovation plans, July 15, 2026
- Cosmetics & Toiletries newsletter, item on Bloomage Biotech and Alaris, November 12, 2026
- Retail Dive, Capri Holdings names Justin Boxford CEO, November 11, 2026
- Oura, announcement of Oura Ring at Ulta Beauty, November 2026